维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="McNeel DG"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer显示文摘	McNeel DG Smith HA Eickhoff JC	2012	Cancer Immunol Immunother2012，61，7：	1
2	MAD-CT-2 identified as a novel melanoma cancer-testis antigen u- sing phage immunoblot analysis 显示文摘	Dubovsky JA Albertini MR McNeel DG	2007	J Immunother2007，30，7：	1
3	Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage DO prostate cancer显示文摘	Mcneel DG Dunphy E J Davies JG	2009	J Clin Oncol2009，27，25：	1
4	Prostate cancer patients on androgen depriva- tion therapy develop persistent changes in adaptive immune responses 显示文摘	Morse MD McNeel DG	2010	Human Immunology2010，71，5：	1
5	Current controversies in the management of biochemical failure in prostate cancer 显示文摘	Bruce JY Lang JM McNeel DG	2012	Clin Adv He- matol Oncol2012，10，11：	1
6	Immune-based therapies for prostate cancer显示文摘	McNeel DG Malkovsky M	2005	Immunol Lett2005，96，：	1
7	Phase I trial of a moneclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion 显示文摘	McNeel DG Eickhoff J Lee FT	2005	Clin Cancer Res2005，11，21：	1
8	DNA vaccines for the treatment of prostate cancer显示文摘	Alam S McNeel DG	2010	Expert Rev Vaccines2010，9，7：	1
9	DNA vaccines for the treatment of prostate cancer显示文摘	Alam S McNeel DG	2010	Expert Rev Vaccines2010，9，7：	1
10	Safety and immunological ef-ficacy of a DNA vaccine encoding prostatic acid phosphatase in pa-tients with stage DO prostate cancer显示文摘	McNeel DG Dunphy EJ Davies JG		0，，：	1
11	A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and pa- clitaxel, in patients with advanced solid tumors 显示文摘	Liu G Kolesar J McNeel DG	2008	Clin Can- cer Res2008，14，9：	1
12	Sipuleucel-T:immunotherapy for advanced prostate cancer显示文摘	Olson BM McNeel DG		0，，：	1
13	Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant 显示文摘	McNeel DG Knutson KL Schiffman K	2003	J Clin Immunol2003，23，1：	1
14	Antibody and T-cell responses speci c for theandrogen receptor in patients with prostate cancer显示文摘	Olson BM McNeel DG	2007	Prostate2007，67，16：	1
15	Pilot study of an HLA-A2 peptide vaccine using fit3 ligand as a systemic vaccine adjuvant显示文摘	McNeel DG Knutson KL Schiffman K	2003	J Clin Immunol2003，23，1：	1
16	DNA vaccines for the treatment of prostate cancer显示文摘	Alam S McNeel DG	2010	Expert Rev Vaccines2010，9，7：	1
17	Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate Cancer显示文摘	McNeel DG Dunphy EJ Davies JG	2009	J Clin Oncol2009，27，25：	1
18	Indncible expression of a pros-tate cancer-testis antigen, SSX-2, following treatment with aDNA methylation inhibitor 显示文摘	Dubousky JA McNeel DG	2007	Prostate2007，67，16：	1
19	Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor显示文摘	McNeel DG Schiffman K Disis ML	1999	Blood1999，93，8：	1
20	A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 ol- igonucleotide g3139, in combination with carboplatin and paclita- xel, in patients with advanced solid tumors显示文摘	Liu G Kolesar J McNeel DG	2008	Clin Cancer Res2008，14，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示